Jessica Toale MP: written questions
Jessica Toale MP: full overview
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 2: 4 Jul 2025 to 3 Jul 2026
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
34 published records · newest first.
Written questions
Health Services: WomenDepartment of Health and Social CareTabled 15 May 2026AnsweredUIN 1837More
Question: To ask the Secretary of State for Health and Social Care, what criteria will govern allocation of the FemTech Challenge Fund; whether successful innovations will be required to demonstrate a clear adoption pathway into NHS services beyond pilot sites befo
Answer: The Renewed Women’s Health Strategy commits to investing £1.5m into a FemTech healthcare challenge. This investment will accelerate the deployment and spread of innovations that benefit women’s health, with a focus on community service models that address...
Answered 1 Jun 2026
Original Parliament recordHealth Services: WomenDepartment of Health and Social CareTabled 15 May 2026AnsweredUIN 1836More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the integration of NHS England functions into his Department on ring-fenced women's health funding being absorbed into wider NHS budgets; and
Answer: The integration of NHS England functions into the Department of Health and Social Care is intended to strengthen accountability and reduce duplication, supporting clearer ways of working across the health system.The transformation does not involve reducti...
Answered 1 Jun 2026
Original Parliament recordHealth Services: WomenDepartment of Health and Social CareTabled 15 May 2026AnsweredUIN 1835More
Question: To ask the Secretary of State for Health and Social Care, what the (a) start and (b) target completion date are for the redesign of clinical pathways for heavy menstrual bleeding, urogynaecology and menopause; and which body will be responsible for report
Answer: The Renewed Women’s Health Strategy, published in April 2026, committed to redesigning clinical pathways for heavy menstrual bleeding, urogynaecology and menopause.These redesigned pathways will create roadmaps for health systems to use and adapt for loca...
Answered 1 Jun 2026
Original Parliament recordHealth Services: WomenDepartment of Health and Social CareTabled 15 May 2026AnsweredUIN 1834More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the renewed Women’s Health Strategy is supported by clear implementation plans, timelines and measurable outcomes.
Answer: The Renewed Women’s Health Strategy for England, published on 15 April 2026, is designed to be implemented through clear actions with defined timelines, responsible delivery organisations and success measures.The summary of actions tables found throughout...
Answered 1 Jun 2026
Original Parliament recordHealth Services: WomenDepartment of Health and Social CareTabled 15 May 2026AnsweredUIN 1833More
Question: To ask the Secretary of State for Health and Social Care, whether Integrated Care Boards will be required to demonstrate alignment with the renewed Women's Health Strategy in annual delivery plans; and what consequences will apply where they do not comply
Answer: The 10-Year Health Plan set out our ambition for high autonomy to be the norm across every part of the country. Integrated care boards (ICBs) are responsible for commissioning services that meet the healthcare needs of their local population and have the ...
Answered 2 Jun 2026
Original Parliament recordHealth Services: WomenDepartment of Health and Social CareTabled 15 May 2026AnsweredUIN 1832More
Question: To ask the Secretary of State for Health and Social Care, which Minister or senior official holds named personal accountability for delivery of each of the four core commitments in the renewed Women's Health Strategy; and whether those accountability arra
Answer: The Renewed Women’s Health Strategy, published on the 15 April 2026, sets out 117 actions across four core commitments:acting on women’s voices and choices;transforming National Health Service performance in services that matter most to women;supporting a...
Answered 1 Jun 2026
Original Parliament recordDental Services: RegulationDepartment of Health and Social CareTabled 3 Feb 2026AnsweredUIN 110572More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure that dental practices are subject to effective regulation.
Answer: The Care Quality Commission (CQC) regulates all health and social care services, including dental services in England. The commission ensures quality and safety across a range of sectors that deliver health and care to people in England.The CQC carries ou...
Answered 9 Feb 2026
Original Parliament recordMeningitis: VaccinationDepartment of Health and Social CareTabled 8 Dec 2025AnsweredUIN 98171More
Question: To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of trends in the level of Meningitis B cases among teenagers and university students; and what steps he is taking to help reduce that level.
Answer: The UK Health Security Agency continually monitors the incidence and profile of invasive meningococcal disease (IMD) in England across all age groups to provide information to the Joint Committee on Vaccination and Immunisation to help inform policy decis...
Answered 5 Jan 2026
Original Parliament recordMeningitis: VaccinationDepartment of Health and Social CareTabled 8 Dec 2025AnsweredUIN 98170More
Question: To ask the Secretary of State for Health and Social Care, when the Joint Committee on Vaccination and Immunisation last reviewed the cost-effectiveness model for providing the Meningitis B vaccine to teenagers; and whether his Department plans to commissi
Answer: In 2013, the Joint Committee on Vaccination and Immunisation (JCVI) advised that the cost-effectiveness of an adolescent Meningitis B (MenB) vaccination programme would be dependent on the impact of the vaccine on protection against meningococcal carriage...
Answered 5 Jan 2026
Original Parliament recordMeningitis: VaccinationDepartment of Health and Social CareTabled 8 Dec 2025AnsweredUIN 98114More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of extending routine NHS vaccination against Meningitis B to teenagers and first-year university students.
Answer: Policy regarding vaccination programmes is based on advice from the Joint Committee on Vaccination and Immunisation (JCVI). The JCVI keeps all vaccination programmes under review, and the meningococcal sub-committee have met a number of times over the pas...
Answered 5 Jan 2026
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82519More
Question: To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of launching a public information campaign to inform individuals born between 1940 and 1980 of the potential risks associated with
Answer: We recognise the consequences for those who were exposed to diethylstilbestrol (DES) and are sorry that women and their families have suffered for far too long.The Department has not made an assessment of the merits of launching a public information campa...
Answered 6 Nov 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82518More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential third-generation health impacts of Diethylstilbestrol exposure; and whether specific research has been commissioned to examine those impacts
Answer: The Government encourages all women, including those exposed to diethylstilbestrol (DES) in utero, to attend regular cervical screenings which test for human papillomavirus, the cause of most cervical cancers. Women who believe or know that they were expo...
Answered 6 Nov 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82517More
Question: To ask the Secretary of State for Health and Social Care, whether his Department plans to update NHS clinical reference materials or NICE guidelines to include information on the diagnosis, management, and screening of patients potentially exposed to Diet
Answer: The National Institute for Health and Care Excellence (NICE) is the national body that develops authoritative, evidence-based guidance for the NHS on best practice in the care and treatment of patients with defined conditions. NICE has not issued any guid...
Answered 6 Nov 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82516More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential implications for his policies of (a) the CDC guidance in the US and (b) other international models for management of Diethylstilbestrol expo
Answer: The Department has not undertaken any specific assessment of the potential implications for its policies of guidance by the Centers for Disease Control and Prevention of the United States or other international models for the management of exposure to die...
Answered 18 Nov 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82515More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the feasibility of using historic medical records to (a) identify and (b) contact people who may have been exposed to diethylstilbestrol.
Answer: We recognise the consequences for those who were exposed to diethylstilbestrol (DES) and offer our sincere sympathies to those who continue to be affected.There have been no discussions between the Department and patient advocacy groups representing peopl...
Answered 6 Nov 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82514More
Question: To ask the Secretary of State for Health and Social Care, what plans his Department has to issue a official apology to those affected by the historical prescription of diethylstilbestrol.
Answer: We recognise the consequences for those who were exposed to diethylstilbestrol (DES) and are sorry that women and their families have suffered for far too long.The Department has not made an assessment of the merits of launching a public information campa...
Answered 6 Nov 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82513More
Question: To ask the Secretary of State for Health and Social Care, what discussions his Department has had with patient advocacy groups representing people affected by diethylstilbestrol exposure.
Answer: We recognise the consequences for those who were exposed to diethylstilbestrol (DES) and offer our sincere sympathies to those who continue to be affected.There have been no discussions between the Department and patient advocacy groups representing peopl...
Answered 6 Nov 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82512More
Question: To ask the Secretary of State for Health and Social Care, what guidance is available to clinicians for patients with a family history of diethylstilbestrol exposure.
Answer: The Government encourages all women, including those exposed to diethylstilbestrol (DES) in utero, to attend regular cervical screenings which test for human papillomavirus, the cause of most cervical cancers. Women who believe or know that they were expo...
Answered 6 Nov 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82511More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has considered the potential merits of a screening protocol for people exposed to diethylstilbestrol.
Answer: The UK National Screening Committee (UK NSC), which advises the Government on all aspects of screening, has never been asked to consider the evidence for a screening programme for people exposed to diethylstilbestrol in utero.Any individual or organisatio...
Answered 24 Oct 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82510More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of NHS screening programmes for the detection of gynaecological cancers linked to diethylstilbestrol exposure.
Answer: The NHS Cervical Screening Programme is the only gynaecological screening programme offered by the National Health Service. On its own, it cannot provide comprehensive care to women exposed to diethylstilbestrol (DES) in utero. This is why the NHS Cervica...
Answered 24 Oct 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82509More
Question: To ask the Secretary of State for Health and Social Care, whether women (a) known and (b) suspected to have exposure to diethylstilbestrol in utero are eligible for enhanced cancer screening.
Answer: Yes, women who believe they have been exposed to diethylstilbestrol (DES) in utero are eligible for enhanced cancer screening. The NHS Cervical Screening Programme guidance reminds providers that these women are eligible for routine cervical screening and...
Answered 24 Oct 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82508More
Question: To ask the Secretary of State for Health and Social Care, whether his Department plans to fund epidemiological research into the potential impact of diethylstilbestrol exposure on third generation people.
Answer: The Department invests over £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR).While no research has been commissioned into the health outcomes of people exposed to diethylstilb...
Answered 24 Oct 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82507More
Question: To ask the Secretary of State for Health and Social Care, what discussions he has had with the (a) UK Health Security Agency and (b) National Institute for Health and Care Research on studies into diethylstilbestrol-related health risks.
Answer: Diethylstilbestrol is a synthetic non-steroidal estrogen medication, which does not fall within the UK Health Security Agency’s remit.Decisions on topics for new or updated guidance from the National Institute for Health and Care Excellence (NICE) are con...
Answered 24 Oct 2025
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82506More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has commissioned research since 2000 into the health outcomes of people exposed to diethylstilbestrol in utero.
Answer: The Department invests over £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR).While no research has been commissioned into the health outcomes of people exposed to diethylstilb...
Answered 24 Oct 2025
Original Parliament recordDiethylstilbestrol: WomenDepartment of Health and Social CareTabled 15 Oct 2025AnsweredUIN 82505More
Question: To ask the Secretary of State for Health and Social Care, whether his Department holds data on the number of women prescribed diethylstilbestrol in (a) England, (b) Scotland, (c) Wales and (d) Northern Ireland between 1939 and 1978.
Answer: This historical information is not held by the Department.
Answered 6 Nov 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →